Which Is More Valuable, Longer Survival or Better Quality of Life? Israeli Oncologists’ and Family Physicians’ Attitudes Toward the Relative Value of New Cancer and Congestive Heart Failure Interventions

Bach, 2009, Limits on Medicare’s ability to control rising spending on cancer drugs, N Engl J Med, 360, 626, 10.1056/NEJMhpr0807774 Neumann, 2012, Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries, Health Aff, 31, 700, 10.1377/hlthaff.2011.1309 Nadler, 2006, Do oncologists believe new cancer drugs offer good value?, Oncologist, 11, 90, 10.1634/theoncologist.11-2-90 Kozminski, 2001, How long and how well: oncologists’ attitudes toward the relative value of life-prolonging vs. quality of life-enhancing treatments, Med Decis Making, 31, 380, 10.1177/0272989X10385847 Berry, 2010, Continental divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs, J Clin Oncol, 28, 4149, 10.1200/JCO.2010.29.1625 Neumann, 2010, Cancer therapy costs influence treatment: a national survey of oncologists, Health Aff, 29, 196, 10.1377/hlthaff.2009.0077 Ubel, 2012, In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gain in survival, Health Aff, 31, 709, 10.1377/hlthaff.2011.0251 Kazi, 2013, The economics of heart failure, Heart Fail Clin, 9, 93, 10.1016/j.hfc.2012.09.005 Mishra, 2010, Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices, J Heart Lung Transplant, 29, 72, 10.1016/j.healun.2009.06.029 Cookson, 2008, Public healthcare resource allocation decisions and the rule of rescue, J Med Ethics, 34, 540, 10.1136/jme.2007.021790 Shmueli, 1999, Survival vs. quality of life: a study of the Israeli public priorities in medical care, Soc Sci Med, 49, 297, 10.1016/S0277-9536(99)00120-3 Tamir O, Rabinovich M, Shani M. Year 2006 update of the Israel National List of Health Services. Isr Med Assoc J 2006;8:595–600. Greenberg, 2009, The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?, Int J Technol Assess Health Care, 25, 255, 10.1017/S026646230999016X Shmueli, 2009, Economic evaluation of the decisions of the Israeli Public Committee for Updating the National List of Health Services in 2006/2007, Value Health, 12, 202, 10.1111/j.1524-4733.2008.00435.x Raftery, 2009, NICE and the challenge of cancer drugs, BMJ, 338, b67, 10.1136/bmj.b67